--- title: "Treatment to adult patients who have 5Q Spinal Muscular Atrophy (SMA) with the Drug Nusinersen" ocid: "ocds-b5fd17-71f47de6-c77d-4b72-a709-718bc752e200" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-b5fd17-71f47de6-c77d-4b72-a709-718bc752e200" markdown_url: "https://d3tenders.com/contract/ocds-b5fd17-71f47de6-c77d-4b72-a709-718bc752e200.md" json_url: "https://d3tenders.com/contract/ocds-b5fd17-71f47de6-c77d-4b72-a709-718bc752e200.json" source: "Contracts Finder" current_stage: "Tender" buyer: "NHS ARDEN AND GREATER EAST MIDLANDS COMMISSIONING SUPPORT UNIT" published: "2019-09-06" --- # Treatment to adult patients who have 5Q Spinal Muscular Atrophy (SMA) with the Drug Nusinersen Buyer: NHS ARDEN AND GREATER EAST MIDLANDS COMMISSIONING SUPPORT UNIT Current stage: Tender OCID: ocds-b5fd17-71f47de6-c77d-4b72-a709-718bc752e200 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-b5fd17-71f47de6-c77d-4b72-a709-718bc752e200) [Download OCDS JSON](https://d3tenders.com/contract/ocds-b5fd17-71f47de6-c77d-4b72-a709-718bc752e200.json) ## Summary NHS Arden and Greater East Midlands Commissioning Support Unit is seeking experienced providers to deliver treatment for adult patients with 5Q Spinal Muscular Atrophy (SMA) using the drug Nusinersen. This procurement falls under the health services industry category, with the tender currently in the planning stage and set to close on 27 September 2019. The contract is expected to commence on 2 January 2020 and will last for three years, with potential extensions up until 24 July 2024, aiming to treat approximately 600 eligible patients across various regions in the United Kingdom. This tender presents a significant opportunity for healthcare providers, particularly those with expertise in neuromuscular disorders and the administration of complex treatments such as intrathecal injections. Businesses that can demonstrate adequate infrastructure for both treatment delivery and patient monitoring will be well-positioned to compete. Given the specific requirements outlined by NHS England, this tender is particularly suited for organisations that cater to specialised medical services and are familiar with compliance processes in public health contracts. ## Notice NHS Arden and Greater East Midlands CSU (AGCSU) on behalf of NHS England Specialised Commissioning is inviting suitably qualified and experienced providers to deliver Treatment to adult patients who have 5Q Spinal Muscular Atrophy (SMA) with the Drug Nusinersen under the Compliance Process specified in Document 1 - Process Overview of process documentation. On 24 July 2019, NICE published Technology appraisal guidance on the use of the drug Nusinersen to treat patients with 5q Spinal Muscular Atrophy (SMA). This is a rare, genetic, neuromuscular disease, characterised by spinal motor neuron loss, muscle atrophy and motor impairment. SMA is debilitating for all patients and fatal for the worst affected; patients and their families can experience extremely high levels of burden. NHS England has agreed a 'Managed Access Agreement (MAA)' for the drug nusinersen for the treatment of eligible patients with spinal muscular atrophy (SMA). The NICE guidance sets out that the drug should only be made available to people who meet the criteria for treatment under the associated MAA. The key objectives of the Compliance Process are: to commission the service(s) to serve adult patients eligible to receive the treatment nationally. It is estimated that 600 patients (adults and children) will be treated in England over the lifetime of the contract. Patients' eligibility and population covered are described in section 4 of the Managed Access Agreement. This may include treating patients from the devolved nations. The Commissioner is seeking to appoint providers who have expertise in the treatment of adults with SMA (from 16-18 years of age, depending on local agreements) and who have the infrastructure both to be able to treat patients with nusinersen (which is given by intrathecal injection) and to collect detailed monitoring information about eligible patients. Providers will need to demonstrate that they are suitably qualified and can meet the agreed service requirements. Further information about scope and qualification requirements can be found in the process documentation published on the EU Supply eTender/Procurement portal (Quote/tender 36955). All communications regarding this opportunity will be managed via the EU Supply messaging service. Additional information: An agreement will be established with the successful applicants for a period of 3 (three) years with the Commissioner having the option to extend the contract until the end of the Managed Access Agreement (24 July 2024). To apply please visit https://uk.eu-supply.com/login.asp?B=UK Quote/tender 36955 - NHS England Spec. Commissioning - Treatment to adult patients who have 5Q Spinal Muscular Atrophy (SMA) with the Drug Nusinersen. ## Key Details | Field | Value | | --- | --- | | Publication source | Contracts Finder | | Latest notice | https://www.contractsfinder.service.gov.uk/Notice/2f322f04-287d-4461-83ba-ed6957027a73 | | Notice type | Tender Notice | | Procurement type | Standard | | Procurement category | Services | | Procurement method | Not Specified | | Procurement method details | Other - | | Tender suitability | Not specified | | Awardee scale | Not specified | | All stages | Tender | ## Dates | Field | Value | | --- | --- | | Publication date | 6 Sep 2019 | | Submission deadline | 27 Sep 2019 | | Future notice date | Not specified | | Award date | Not specified | | Contract period | 2 Jan 2020 - 1 Jan 2023 | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | Not specified | | Lots value | Not specified | | Awards value | Not specified | | Contracts value | Not specified | ## Status | Field | Value | | --- | --- | | Tender status | Active | | Lots status | Not specified | | Awards status | Not specified | | Contracts status | Not specified | ## Buyer | Field | Value | | --- | --- | | Main buyer | NHS ARDEN AND GREATER EAST MIDLANDS COMMISSIONING SUPPORT UNIT | | Locality | LONDON | | Post town | South East London | | Postcode | SE1 6LH | | Country | England | | ITL 1 | TLI London | | ITL 2 | TLI4 Inner London - East | | ITL 3 | TLI44 Lewisham and Southwark | | Local authority | Southwark | | Electoral ward | St George's | | Westminster constituency | Bermondsey and Old Southwark | | Delivery location | TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLI London, TLJ South East (England), TLK South West (England), TLL Wales, TLN Northern Ireland | ## CPV Codes ### Divisions - 85 - Health and social work services ### Codes - 85100000 - Health services ## Release History - 6 Sep 2019 at 19:33 - Tender - Tender Notice - https://www.contractsfinder.service.gov.uk/Notice/2f322f04-287d-4461-83ba-ed6957027a73 ## Documents - https://www.contractsfinder.service.gov.uk/Notice/2f322f04-287d-4461-83ba-ed6957027a73 6th September 2019 - Opportunity notice on Contracts Finder ## Notice URLs - https://uk.eu-supply.com/login.asp?B=UK - https://www.england.nhs.uk/commissioning/spec-services/ ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-b5fd17-71f47de6-c77d-4b72-a709-718bc752e200. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-b5fd17-71f47de6-c77d-4b72-a709-718bc752e200.json.